Prudential Financial
TNXP icon

Prudential Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

Prudential Financial’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-977
Closed -$68.1K – 2799
2024
Q2 		$68.1K Buy
977
+935
+2,226% +$424K ﹤0.01% 2582
2024
Q1 		$25.1K Buy
+42
New +$45.2K ﹤0.01% 2643
2022
Q2 		– Hold
0
– -$5K – 2745
2022
Q1 		– Sell
-11
Closed -$1.68M – 2603
2021
Q4 		$2.48M Buy
11
+10
+1,000% +$3.18M ﹤0.01% 1411
2021
Q3 		$206K Buy
+1
New +$487K ﹤0.01% 2469
2021
Q2 		– Hold
0
– – – 2537

Other funds holding TNXP

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

Prudential Financial's TNXP Position: Q3 2024 in Review

Prudential Financial sold out of Tonix Pharmaceuticals (TNXP) in Q3 2024, closing a stake of 977 shares — an estimated $68.1K sold.

Prudential Financial first reported a position in TNXP in Q3 2021 and held it in 4 quarters. The position peaked at $2.48M in Q4 2021. 16 funds tracked by Wall St. Rank hold TNXP as of Q3 2024.

  • Prudential Financial reported no remaining Tonix Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Prudential Financial sold 977 Tonix Pharmaceuticals shares in Q3 2024, an estimated $68.1K.
  • Prudential Financial first reported a position in Tonix Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Prudential Financial's Tonix Pharmaceuticals position peaked at $2.48M in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.